Filter by Brand
Filter by Topic
Look beyond numbers to measure the value of medical affairs
Determining and communicating the value of medical affairs requires qualitative analysis that goes beyond simple numbers.
5 reasons to work with rising stars
Emerging healthcare providers and rising stars can support life sciences companies’ product success from development through commercialization.
Reshaping medical affairs for 2022
Medical affairs leaders need to seek out new data sources, competencies and technology solutions to bring greater transparency and collaboration to...
Expanded payment data & expert selection
Monocl ExpertInsight has long featured US Industry Payment data – this week we’ve added payment data from another 35 countries – mainly from European...
Use of analytics in medical affairs
Until very recently, functional operations for many Medical Affairs teams relied on legacy processes underpinned by multiple, disconnected systems.
How to find clinical leadership with Monocl
Monocl’s global dataset allows users to analyze the US healthcare system, regardless of diagnosis or procedure, to gain valuable insights into...
Considering digital influencers
How teams can prepare for the upcoming shortage of oncologists and the changing communication preferences of a new generation of physicians.
Navigating a changing oncology space
How teams can prepare for the upcoming shortage of oncologists and the changing communication preferences of a new generation of physicians
Steps to MSL success in rare disease medical affairs
Malia Lewin has held executive-level roles at the International Psoriasis Council, Ascension Health, Rivermark LLC, Veeva Systems, and most recently...
Behavioral science in medical affairs
COVID-19 may be the unlikely kick-start to reverse public perception of the pharmaceutical industry and, ultimately, enhance the patient experience.
